Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: Jim Oravetz who wrote (2463)	1/5/2001 2:02:55 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 52153

Thanks, Jim. I love this logic. Over valuation is (was) generally restricted to sector issues that have "Street" sponsorship. The very individuals/organizations that created the froth are those who now criticize valuations. Did anbody FORCE the underwriters to offer shares at 4X their current value? Those organizations and "the media" do everything they can to cloud these issues and to hide the fact that $$$$$ are made from the excesses. Dotcoms, biotechs..... underwriters have made a ton of money, taking it from the naive. I'd love to assign analysts to their own personal hell...... an obligation to make a living from their own advice and knowledge. Hope all are well! Rick